← All companies

ANAB

AnaptysBio, Inc.

ANAB Nasdaq Pharmaceutical Preparations EDGAR ↗

$53.66

+0.30 +0.56%

Key statistics

from XBRL data in SEC filings

Market cap

$1.56B

Revenue (TTM)

$232M

Net income (TTM)

-$26.8M

EPS (TTM)

$-1.02

P/E ratio

—

Dividend yield

—

Free cash flow

$19.6M

Cash

$248M

Total assets

$330M

Gross margin

—

52-week range

$11.40 – $72.36

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 30, 2026 8-K Entered a material agreement Jun 22, 2026 8-K Regulation FD disclosure May 29, 2026 8-K Amended charter or bylaws May 21, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Director or officer change May 11, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 28, 2026 8-K/A Apr 24, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Director or officer change; Other events Apr 20, 2026 8-K Entered a material agreement; Terminated a material agreement; Director or officer change; Regulation FD disclosure Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 3, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2026 8-K Regulation FD disclosure Nov 26, 2025 8-K Other events Nov 21, 2025 8-K Other events Nov 21, 2025 8-K Regulation FD disclosure; Other events Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Regulation FD disclosure Oct 14, 2025 8-K Regulation FD disclosure; Other events Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 17, 2025 8-K Regulation FD disclosure; Other events Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release) May 5, 2025 8-K Other events Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Regulation FD disclosure Feb 19, 2025 8-K Regulation FD disclosure; Other events Feb 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Feb 3, 2025 8-K Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Entered a material agreement Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024